Business Description
Embecta Corp
NAICS : 325414
SIC : 3841
ISIN : US29082K1051
Total Employee Number:
1,850Description
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.14 | |||||
Equity-to-Asset | -0.61 | |||||
Debt-to-Equity | -2.17 | |||||
Debt-to-EBITDA | 4.35 | |||||
Interest Coverage | 2.9 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.79 | |||||
Beneish M-Score | -3.13 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -2.3 | |||||
3-Year EBITDA Growth Rate | -6.1 | |||||
3-Year EPS without NRI Growth Rate | -14.9 | |||||
3-Year FCF Growth Rate | -22.9 | |||||
3-Year Book Growth Rate | 10.7 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.46 | |||||
Quick Ratio | 1.68 | |||||
Cash Ratio | 0.75 | |||||
Days Inventory | 167.55 | |||||
Days Sales Outstanding | 57.44 | |||||
Days Payable | 63.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Payout Ratio | 0.23 | |||||
3-Year Dividend Growth Rate | 58.7 | |||||
3-Year Average Share Buyback Ratio | -0.8 | |||||
Shareholder Yield % | 96.6 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 61.88 | |||||
Operating Margin % | 27.67 | |||||
Net Margin % | 10.73 | |||||
EBITDA Margin % | 29.91 | |||||
FCF Margin % | 19.82 | |||||
OCF Margin % | 20.67 | |||||
ROE % | Neg. Equity | |||||
ROA % | 10.24 | |||||
ROIC % | 29.78 | |||||
3-Year ROIIC % | -76.18 | |||||
ROC (Joel Greenblatt) % | 62.48 | |||||
ROCE % | 32.15 | |||||
Years of Profitability over Past 10-Year | 7 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 1.83 | |||||
Forward PE Ratio | 18.23 | |||||
PE Ratio without NRI | 1.34 | |||||
Price-to-Owner-Earnings | 1.31 | |||||
PS Ratio | 0.2 | |||||
Price-to-Free-Cash-Flow | 1 | |||||
Price-to-Operating-Cash-Flow | 0.96 | |||||
EV-to-EBIT | 5.13 | |||||
EV-to-EBITDA | 4.42 | |||||
EV-to-Revenue | 1.32 | |||||
EV-to-FCF | 6.74 | |||||
Price-to-GF-Value | 0.27 | |||||
Earnings Yield (Greenblatt) % | 19.49 | |||||
FCF Yield % | 99.15 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Embecta Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MXN) | 19,160.408 | ||
| EPS (TTM) (MXN) | 35.28 | ||
| Beta | -0.0008 | ||
| 3-Year Sharpe Ratio | -65.65 | ||
| 3-Year Sortino Ratio | -3.46 | ||
| Volatility % | 0.85 | ||
| 14-Day RSI | - | ||
| 14-Day ATR (MXN) | - | ||
| 20-Day SMA (MXN) | 497.96 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (MXN) | 497.96 - 497.96 | ||
| Shares Outstanding (Mil) | 59.33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Embecta Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Embecta Corp Stock Events
| Event | Date | Price (MXN) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2026-11-25 08:00 | In 150 days | ||
| Annual report for 2026 | 2026-11-25 | In 149 days | ||
| Fourth quarter earnings results for 2026 | 2026-11-25 | In 149 days | ||
| Third quarter earnings conference call for 2026 | 2026-08-07 08:00 | In 40 days | ||
| Third quarter earnings results for 2026 | 2026-08-07 | In 39 days | ||
| USD 0.010000 Cash Dividend | 2026-05-28 | 497.96 (+0.00%) | ||
| Guidance call for 2026 | 2026-05-13 18:00 | 497.96 (+0.00%) | ||
| Second quarter earnings conference call for 2026 | 2026-05-05 08:00 | 497.96 (+0.00%) | ||
| Second quarter earnings results for 2026 | 2026-05-05 | 497.96 (+0.00%) | ||
| USD 0.150000 Cash Dividend | 2026-02-27 | 497.96 (+0.00%) |
Show
Entries
Embecta Corp Frequently Asked Questions
What is Embecta Corp(MEX:EMBC)'s stock price today?
The current price of MEX:EMBC is MXN497.96. The 52 week high of MEX:EMBC is MXN497.96 and 52 week low is MXN497.96.
When is next earnings date of Embecta Corp(MEX:EMBC)?
The next earnings date of Embecta Corp(MEX:EMBC) is 2026-08-07 Est..
Does Embecta Corp(MEX:EMBC) pay dividends? If so, how much?
Embecta Corp(MEX:EMBC) does not pay dividend.
Press Release
Articles on Embecta Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers